{
  "resourceType" : "MedicationRequest",
  "id" : "mii-exa-mtb-medication-request-trastuzumab-deruxtecan",
  "meta" : {
    "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-therapieempfehlung|2026.0.1"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationRequest mii-exa-mtb-medication-request-trastuzumab-deruxtecan</b></p><a name=\"mii-exa-mtb-medication-request-trastuzumab-deruxtecan\"> </a><a name=\"hcmii-exa-mtb-medication-request-trastuzumab-deruxtecan\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mii-pr-mtb-therapieempfehlung.html\">MII PR MTB Therapieempfehlung Systemische Therapieversion: null2026.0.1)</a></p></div><p><b>MII EX MTB Empfehlung Priorität</b>: 3</p><p><b>MII EX MTB Empfehlung Evidenzgraduierung</b>: <span title=\"Codes:{https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad m1B}\">m1B</span></p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://www.ncbi.nlm.nih.gov/pubmed</code>/35665782</p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://www.ncbi.nlm.nih.gov/pubmed</code>/37870536</p><p><b>MII EX MTB Empfehlung Publikation</b>: <code>http://doi.org</code>/10.1200/JCO.2023.41.17_suppl.LBA3000</p><p><b>status</b>: Draft</p><p><b>intent</b>: Proposal</p><p><b>medication</b>: <span title=\"Codes:{http://fhir.de/CodeSystem/bfarm/atc L01FD04}\">Trastuzumab deruxtecan</span></p><p><b>subject</b>: <a href=\"Patient-PatientKimMusterperson.html\">Kim Musterperson  (no stated gender), DoB: 1956-03-14</a></p><p><b>authoredOn</b>: 2023-03-28</p><p><b>reasonReference</b>: <a href=\"Condition-PatientKimMusterperson-PrimaryDiagnosis-2.html\">Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet</a></p></div>"
  },
  "extension" : [{
    "url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-prioritaet",
    "valuePositiveInt" : 3
  },
  {
    "url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-evidenzgraduierung",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/CodeSystem/mii-cs-mtb-empfehlung-evidenzgrad",
        "code" : "m1B"
      }]
    }
  },
  {
    "url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation",
    "valueIdentifier" : {
      "system" : "http://www.ncbi.nlm.nih.gov/pubmed",
      "value" : "35665782"
    }
  },
  {
    "url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation",
    "valueIdentifier" : {
      "system" : "http://www.ncbi.nlm.nih.gov/pubmed",
      "value" : "37870536"
    }
  },
  {
    "url" : "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-ex-mtb-empfehlung-publikation",
    "valueIdentifier" : {
      "system" : "http://doi.org",
      "value" : "10.1200/JCO.2023.41.17_suppl.LBA3000"
    }
  }],
  "status" : "draft",
  "intent" : "proposal",
  "medicationCodeableConcept" : {
    "coding" : [{
      "system" : "http://fhir.de/CodeSystem/bfarm/atc",
      "version" : "2025",
      "code" : "L01FD04",
      "display" : "Trastuzumab deruxtecan"
    }]
  },
  "subject" : {
    "reference" : "Patient/PatientKimMusterperson"
  },
  "authoredOn" : "2023-03-28",
  "reasonReference" : [{
    "reference" : "Condition/PatientKimMusterperson-PrimaryDiagnosis-2"
  }]
}